Mary Thistle
Director/Board Member chez ENTRADA THERAPEUTICS, INC.
Fortune : 5 430 $ au 31/03/2024
Profil
Mary T.
Thistle is currently serving as a Director at Cocoon Biotech, Inc., an Independent Director at Enterome SA since 2017, an Independent Director at Entrada Therapeutics, Inc. since 2021, an Independent Director at Vigil Neuroscience, Inc. since 2022, and a Director at Q32 Bio, Inc. Additionally, Ms. Thistle has held former positions as an Independent Director at Alaunos Therapeutics, Inc. from 2020 to 2023, an Independent Director at Homology Medicines, Inc., a Senior Vice President-Business Development at Cubist Pharmaceuticals LLC from 2014 to 2015, a Senior Vice President-Business Development at ViaCell, Inc., an Accountant at Deloitte & Touche LLP, a Principal at Sierra Research & Technology, Inc., a Consultant at Yoshida & Sokolski PC, a Senior Vice President-Business Development at PerkinElmer, Inc. from 2007 to 2008, the Chief Financial & Accounting Officer at Dimension Therapeutics, Inc. in 2017, and a Special Advisor at Bill & Melinda Gates Medical Research Institute from 2020 to 2022.
Ms. Thistle completed her undergraduate degree at the University of Massachusetts in 1983.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/06/2023 | 3 000 ( 0,02% ) | 5 430 $ | 31/03/2024 | |
ENTRADA THERAPEUTICS INC
-.--% | 08/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
-.--% | 25/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
VIGIL NEUROSCIENCE, INC.
-.--% | 07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Mary Thistle
| Sociétés | Poste | Début |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Director/Board Member | 04/05/2021 |
| VIGIL NEUROSCIENCE, INC. | Director/Board Member | 18/04/2022 |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Director/Board Member | 01/01/2017 |
Cocoon Biotech, Inc.
 Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Anciens postes connus de Mary Thistle
| Sociétés | Poste | Fin |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 18/12/2023 |
Bill & Melinda Gates Medical Research Institute
 Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Medical Research Institute is a non-profit organization that focuses on reducing the burden of tuberculosis, malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs). The private company is based in Cambridge, MA. The company works through collaborating partners and organizations to develop and effectively use novel biomedical interventions to address substantial health concerns. | Human Resources Officer | 01/10/2020 |
| DIMENSION THERAPEUTICS INC | Director of Finance/CFO | 01/12/2017 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2015 |
PerkinElmer, Inc.
 PerkinElmer, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Excelitas Technologies Holding Corp., PerkinElmer, Inc. /IDS Business/ provides analytical and laboratory solutions. Prahlad Ramadhar Singh has been the CEO of the American company since 2009. | Corporate Officer/Principal | 01/01/2008 |
Formation de Mary Thistle
| University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| VIGIL NEUROSCIENCE, INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
Cocoon Biotech, Inc.
Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Sierra Research & Technology, Inc.
 Sierra Research & Technology, Inc. Information Technology ServicesTechnology Services Part of Analog Devices, Inc., Sierra Research & Technology, Inc. designs intellectual property and cores for the high speed networking and display driver markets. The private company is based in Mountain View, CA. Sierra Research & Technology was acquired by Teridian Semiconductor Corp., part of Analog Devices, Inc. from May 11, 2010 on December 20, 2000. | Technology Services |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
Yoshida & Sokolski PC
 Yoshida & Sokolski PC Miscellaneous Commercial ServicesCommercial Services Yoshida & Sokolski PC is a private company based in Burlington, MA. | Commercial Services |
PerkinElmer, Inc.
PerkinElmer, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Excelitas Technologies Holding Corp., PerkinElmer, Inc. /IDS Business/ provides analytical and laboratory solutions. Prahlad Ramadhar Singh has been the CEO of the American company since 2009. | Commercial Services |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Bill & Melinda Gates Medical Research Institute
Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services The Bill & Melinda Gates Medical Research Institute is a non-profit organization that focuses on reducing the burden of tuberculosis, malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs). The private company is based in Cambridge, MA. The company works through collaborating partners and organizations to develop and effectively use novel biomedical interventions to address substantial health concerns. | Commercial Services |
